Growing Market Presence PeraHealth has recently been acquired by Spacelabs Healthcare, indicating strong investor confidence and expanding market influence within the healthcare AI and analytics sector, presenting opportunities for partners looking to collaborate with a recognized industry innovator.

Innovative Technology Focus With FDA-cleared tools like the Rothman Index and ongoing development of mobile applications for COVID-19 and general patient monitoring, PeraHealth offers cutting-edge solutions that can enhance hospital operational efficiency and clinical decision-making across various healthcare settings.

Strategic Partnerships Partnerships with recognized healthcare providers such as Akron Children’s Hospital and Holzer Health System demonstrate a proven track record of successful client adoption, providing a foundation for expanding sales efforts through targeted outreach to similar institutional clients.

Funding and Revenue Potential With a current revenue range of 1 to 10 million dollars and secured funding of 14 million dollars, PeraHealth is positioned for growth, making it an attractive prospect for investors and partners interested in scaling AI-driven healthcare solutions.

Focus on Clinical Outcomes The company's award-winning use of the Rothman Index to improve patient outcomes and its focus on clinical innovation create opportunities to introduce enhanced analytics tools and supplemental services to healthcare organizations aiming for better quality metrics and operational results.